首页> 外国专利> Method for producing megakaryocytes and thrombocytes derived from human myelogenous leukemia cells

Method for producing megakaryocytes and thrombocytes derived from human myelogenous leukemia cells

机译:源自人骨髓性白血病细胞的巨核细胞和血小板细胞的生产方法

摘要

The present invention relates to a method for inducing differentiation of human myeloid leukemia cell line into megakaryocytes and platelets. More particularly, the present invention relates to a method for inducing the differentiation of human myeloid leukemia cell line into megakaryocytes and thrombocytes by treating a composition comprising phytosphingosine as an active ingredient, And the phytosphingosine can exhibit high efficiency even at a low concentration as compared with the conventional megakaryocytic differentiation inducing compound. In addition, co-culturing with OP9 cells is not required, and it is possible to induce megakaryocyte differentiation only by using alone, and these megakaryocytes and platelets generated therefrom can be used for treatment of thrombocytopenia and the like.
机译:本发明涉及一种诱导人骨髓白血病细胞系分化为巨核细胞和血小板的方法。更具体地,本发明涉及通过处理包含植物鞘氨醇作为活性成分的组合物来诱导人骨髓性白血病细胞系分化为巨核细胞和血小板细胞的方法,并且即使与低浓度的植物鞘氨醇相比,该植物鞘氨醇也可以表现出高效率。常规的巨核细胞分化诱导化合物。另外,不需要与OP9细胞共培养,并且可以仅通过单独使用来诱导巨核细胞分化,并且这些巨核细胞和由此产生的血小板可以用于治疗血小板减少症等。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号